Sprodiamide

Sprodiamide (Dy-DTPA-BMA) is a susceptibility-based MRI contrast agent that can be used to visualize image intensity changes during vascular transport of drugs[1].

Product Specifications

CAS Number

[128470-17-7]

Product Name Alternative

Dy-DTPA-BMA

UNSPSC

12171500

Target

Biochemical Assay Reagents

Type

Reference compound

Related Pathways

Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/sprodiamide.html

Smiles

CNC1=O[Dy+3]234([O-]5)([O-]6)([O-]7)[N](CC[N]2(CC6=O)CC[N]3(CC5=O)CC(NC)=O4)(CC7=O)C1

Molecular Formula

C16H26DyN5O8

Molecular Weight

578.91

References & Citations

[1]Lai J J, et al. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of Sprodiamide Injection, a new contrast medium for magnetic resonance imaging[J]. Journal of pharmaceutical and biomedical analysis, 1993, 11 (11-12) : 1129-1134.